Comparison 4. Azathioprine + infliximab versus infliximab.
Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
---|---|---|---|---|
1 Maintenance of remission | 1 | Risk Ratio (M‐H, Fixed, 95% CI) | Totals not selected | |
2 Adverse events | 1 | Risk Ratio (M‐H, Fixed, 95% CI) | Totals not selected | |
3 Withdrawals due to adverse events | 1 | Risk Ratio (M‐H, Fixed, 95% CI) | Totals not selected | |
4 Serious adverse events | 1 | Risk Ratio (M‐H, Fixed, 95% CI) | Totals not selected |